Bottom line
Is NMAVX a good fund? The bottom line
NMAVX is the Investor Class share class of Nuance Mid Cap Value Fund, a managed mid-cap mutual fund from Tortoise.
Annual fees run 1.21% — about $121 a year on every $10,000 invested, more expensive than 78% of mid-cap funds we track.
It returned −1.4% over one year, +3.1% a year over five years, +7.6% a year over ten (as of Dec 31, 2025, per its prospectus).
With $295 million in net assets and 62 holdings, its largest position is Qiagen Nv (7.2%) and the top 10 make up 46.2% of the portfolio.
This share class carries a front-end sales charge of up to 5%; a no-load class or ETF alternative can avoid it.
What to watch
- Expensive for its category (1.21%)
- 5-year return in the bottom quarter of its category
- Front-end sales load up to 5%
- 12b-1 marketing fee of 0.25% a year
- High turnover (11% a year) can mean more taxable distributions
Updated Nov 19, 2026
What NMAVX invests in
The Nuance Mid Cap Value Fund (the Fund or Mid Cap Value Fund) seeks long-term capital appreciation.
The Fund invests primarily in equity securities of companies that Nuance Investments, LLC (the Adviser) believes are high quality, though temporarily out of favor. Under normal market conditions, the Fund invests at least 80% of its net assets (plus any borrowings for investment purposes) in securities issued by mid-capitalization companies. The Adviser defines mid- capitalization companies as companies within the range of the capitalization of companies constituting the Russell Midcap Index. The Adviser intends to manage the Fund so that the average weighted market capitalization of its portfolio (derived from FactSet and excluding short-term investments) falls within the range of the smallest and largest members of the Russell Midcap Index, as determined by averaging the smallest and largest members month end market capitalization over the last 12 months. As of June 30, 2026, the…
From the fund's prospectus (filed Aug 28, 2026).
NMAVX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| NMAVX | −1.4% | +3.1% | +7.6% |
| Mid-Cap median | +7.9% | +8.1% | +9.9% |
Source: Fund prospectus, as of Dec 31, 2025
What NMAVX costs
On a $10,000 investment, NMAVX's 1.21% expense ratio costs about $121 a year. The prospectus estimates $2,002 in total costs over 10 years (assuming 5% annual returns). The median mid-cap fund charges 0.88%.
NMAVX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Qiagen Nv QGEN | 7.19% |
| 2 | First American Government Obli | 6.60% |
| 3 | California Water Service Group CWT | 5.82% |
| 4 | Beiersdorf AG BDRFY | 5.70% |
| 5 | Clorox Co/The CLX | 5.27% |
| 6 | Kenvue Inc KVUE | 3.48% |
| 7 | Charles Schwab Corp SCHW | 3.37% |
| 8 | Solventum Corp SOLV | 3.01% |
| 9 | Bio-Techne Corp TECH | 2.98% |
| 10 | Henkel AG & Co KGaA HENKY | 2.78% |
Source: SEC Form N-PORT, period ended Jul 31, 2026
The top 10 make up 46.2% of the fund. See all top 25 holdings and asset mix →